Fresenius SE & CO KGaA : Only upside from now on
>Evaluation of businesses with ultimate goal to reduce costs - The Q3 results consisted of the first presentation of Michael Sen as new CEO of the company. While the 3+1 strategy (rollout nutrition, expand on medtech, broaden biopharma + building resilience in volume business) at Kabi was already implemented during his time as divisional CEO, he reported being 50% ahead of plan on cost savings as well as the divestment of non-core assets. The expected positive contrib...Fresenius is a health care group providing products and services for dialysis, hospitals and outpatient medical care. Co. operates four business segments: Fresenius Medical Care; Fresenius Kabi; Fresenius Helios; and Fresenius Vamed. Fresenius Medical Care provides dialysis care and dialysis products for patients with chronic kidney failure. Fresenius Kabi is engaged in the provision of generic drugs, infusion therapies, clinical nutrition products, related medical devices and transfusion technology. Fresenius Vamed manages projects and provides services for hospitals and other health care facilities. Fresenius Helios is a private hospital operator which only operates in Germany.
Oddo Securities provides securities brokerage and research services. The company offers equity, economic, and derivatives research and credit analysis services. It focuses on insurance, automotive, building materials, pharmaceuticals, telecommunications, information technology, and agri-food industries.
Unfortunately, this report is not available for the investor type or country you selected.
Browse all ResearchPool reportsReport is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.